Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Experimentos Relacionados

Defectos de nacimiento y terminales de visualización de video.

K Kurppa, P C Holmberg, K Rantala

    Lancet (London, England)
    |December 8, 1984
    PubMed
    Resumen

    No abstract available in PubMed .

    Videos de Experimentos Relacionados

    Videos de Conceptos Relacionados

    También podría leer

    Artículos Relacionados

    Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

    Ordenar por
    Same author

    A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

    Clinical rheumatology·2018
    Same author

    Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

    Clinical rheumatology·2018
    Same author

    Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in coeliac disease.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis.

    Arthritis care & research·2016
    Same author

    Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016